These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 23670818)
21. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease. Wu X; Kosaraju J; Zhou W; Tam KY ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988 [TBL] [Abstract][Full Text] [Related]
22. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease. Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679 [TBL] [Abstract][Full Text] [Related]
23. Repeated cognitive stimulation alleviates memory impairments in an Alzheimer's disease mouse model. Martinez-Coria H; Yeung ST; Ager RR; Rodriguez-Ortiz CJ; Baglietto-Vargas D; LaFerla FM Brain Res Bull; 2015 Aug; 117():10-5. PubMed ID: 26162480 [TBL] [Abstract][Full Text] [Related]
24. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model. Walker JM; Klakotskaia D; Ajit D; Weisman GA; Wood WG; Sun GY; Serfozo P; Simonyi A; Schachtman TR J Alzheimers Dis; 2015; 44(2):561-72. PubMed ID: 25318545 [TBL] [Abstract][Full Text] [Related]
25. Fluoxetine effects on behavior and adult hippocampal neurogenesis in female C57BL/6J mice across the estrous cycle. Yohn CN; Shifman S; Garino A; Diethorn E; Bokka L; Ashamalla SA; Samuels BA Psychopharmacology (Berl); 2020 May; 237(5):1281-1290. PubMed ID: 31965254 [TBL] [Abstract][Full Text] [Related]
26. Isoflurane mediated neuropathological and cognitive impairments in the triple transgenic Alzheimer's mouse model are associated with hippocampal synaptic deficits in an age-dependent manner. Joseph DJ; Liu C; Peng J; Liang G; Wei H PLoS One; 2019; 14(10):e0223509. PubMed ID: 31600350 [TBL] [Abstract][Full Text] [Related]
27. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease. Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000 [TBL] [Abstract][Full Text] [Related]
28. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Wu X; Kosaraju J; Zhou W; Tam KY Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769 [TBL] [Abstract][Full Text] [Related]
29. Spatial coding defects of hippocampal neural ensemble calcium activities in the triple-transgenic Alzheimer's disease mouse model. Lin X; Chen L; Baglietto-Vargas D; Kamalipour P; Ye Q; LaFerla FM; Nitz DA; Holmes TC; Xu X Neurobiol Dis; 2022 Jan; 162():105562. PubMed ID: 34838667 [TBL] [Abstract][Full Text] [Related]
30. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice. Clark JK; Furgerson M; Crystal JD; Fechheimer M; Furukawa R; Wagner JJ Neurobiol Learn Mem; 2015 Nov; 125():152-162. PubMed ID: 26385257 [TBL] [Abstract][Full Text] [Related]
31. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice. Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439 [TBL] [Abstract][Full Text] [Related]
32. Protective effects of Alpinae Oxyphyllae Fructus extracts on lipopolysaccharide-induced animal model of Alzheimer's disease. Wang Y; Wang M; Fan K; Li T; Yan T; Wu B; Bi K; Jia Y J Ethnopharmacol; 2018 May; 217():98-106. PubMed ID: 29447949 [TBL] [Abstract][Full Text] [Related]
33. Physical exercise during exposure to 40-Hz light flicker improves cognitive functions in the 3xTg mouse model of Alzheimer's disease. Park SS; Park HS; Kim CJ; Kang HS; Kim DH; Baek SS; Kim TW Alzheimers Res Ther; 2020 May; 12(1):62. PubMed ID: 32434556 [TBL] [Abstract][Full Text] [Related]
34. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. Bianchi P; Ciani E; Guidi S; Trazzi S; Felice D; Grossi G; Fernandez M; Giuliani A; Calzà L; Bartesaghi R J Neurosci; 2010 Jun; 30(26):8769-79. PubMed ID: 20592198 [TBL] [Abstract][Full Text] [Related]
35. Fluoxetine induces input-specific hippocampal dendritic spine remodeling along the septotemporal axis in adulthood and middle age. McAvoy K; Russo C; Kim S; Rankin G; Sahay A Hippocampus; 2015 Nov; 25(11):1429-46. PubMed ID: 25850664 [TBL] [Abstract][Full Text] [Related]
36. Learning impairment by minimal cortical injury in a mouse model of Alzheimer's disease. Zou J; Wang M; Uchiumi O; Shui Y; Ishigaki Y; Liu X; Tajima N; Akai T; Iizuka H; Kato N Brain Res; 2016 Apr; 1637():56-63. PubMed ID: 26876740 [TBL] [Abstract][Full Text] [Related]
37. Transcranial direct current stimulation does not improve memory deficits or alter pathological hallmarks in a rodent model of Alzheimer's disease. Gondard E; Soto-Montenegro ML; Cassol A; Lozano AM; Hamani C J Psychiatr Res; 2019 Jul; 114():93-98. PubMed ID: 31054455 [TBL] [Abstract][Full Text] [Related]
38. Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice. Marlatt MW; Lucassen PJ; van Praag H Brain Res; 2010 Jun; 1341():93-9. PubMed ID: 20381469 [TBL] [Abstract][Full Text] [Related]
39. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques. Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884 [TBL] [Abstract][Full Text] [Related]
40. Location is everything: neurons born during fluoxetine treatment accumulate in regions that do not support spatial learning. Satvat E; Gheidi A; Voll S; Odintsova IV; Marrone DF Neuropharmacology; 2012 Mar; 62(4):1627-33. PubMed ID: 22182782 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]